These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 31864201)
1. Diagnostic value of PET/CT versus PET/MRI in gynecological malignancies of the pelvis: A meta-analysis. Virarkar M; Ganeshan D; Devine C; Bassett R; Kuchana V; Bhosale P Clin Imaging; 2020 Mar; 60(1):53-61. PubMed ID: 31864201 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic role of 18F-FDG PET/MRI in patients with gynecological malignancies of the pelvis: A systematic review and meta-analysis. Nie J; Zhang J; Gao J; Guo L; Zhou H; Hu Y; Zhu C; Li Q; Ma X PLoS One; 2017; 12(5):e0175401. PubMed ID: 28481958 [TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis. Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513 [TBL] [Abstract][Full Text] [Related]
4. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis. Lin CY; Lin CL; Kao CH Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261 [TBL] [Abstract][Full Text] [Related]
5. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis. Zhang C; Liang Z; Liu W; Zeng X; Mo Y BMC Cancer; 2023 Jan; 23(1):37. PubMed ID: 36624425 [TBL] [Abstract][Full Text] [Related]
6. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis. Wei J; Pei S; Zhu X Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126 [TBL] [Abstract][Full Text] [Related]
7. Performance of Different Imaging Techniques for Detection of Para-Aortic Lymph Node Metastasis from Gynecological Malignancies: A Systematic Review and Meta-Analysis. Gong Y; Guo Z; Tang X; Li C; Wang Q Gynecol Obstet Invest; 2020; 85(1):53-71. PubMed ID: 31505492 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis. Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of FDG-PET versus magnetic resonance imaging for detecting spondylitis: a systematic review and meta-analysis. Yin Y; Liu X; Yang X; Guo J; Wang Q; Chen L Spine J; 2018 Dec; 18(12):2323-2332. PubMed ID: 30121323 [TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer. Qu X; Huang X; Yan W; Wu L; Dai K Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with Merkel cell carcinoma: a systematic review and meta-analysis. Treglia G; Kakhki VR; Giovanella L; Sadeghi R Am J Clin Dermatol; 2013 Dec; 14(6):437-47. PubMed ID: 23959776 [TBL] [Abstract][Full Text] [Related]
12. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma. Lee JW; Nam SB; Kim SJ Oncology; 2019; 97(5):286-293. PubMed ID: 31437839 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of 18F-FDG-PET in patients with testicular cancer: a meta-analysis. Zhao JY; Ma XL; Li YY; Zhang BL; Li MM; Ma XL; Liu L Asian Pac J Cancer Prev; 2014; 15(8):3525-31. PubMed ID: 24870751 [TBL] [Abstract][Full Text] [Related]
15. Comparison of 18F-FDG PET/CT with bone scintigraphy for detection of bone metastasis: a meta-analysis. Cheng X; Li Y; Xu Z; Bao L; Li D; Wang J Acta Radiol; 2011 Sep; 52(7):779-87. PubMed ID: 21712464 [TBL] [Abstract][Full Text] [Related]
16. Head-to-Head Comparison of the Diagnostic Performance of FDG PET/CT and FDG PET/MRI in Patients With Cancer: A Systematic Review and Meta-Analysis. Singnurkar A; Poon R; Metser U AJR Am J Roentgenol; 2024 Sep; 223(3):e2431519. PubMed ID: 39016450 [No Abstract] [Full Text] [Related]
17. Diagnostic value of 18F-FDG PET/MRI in recurrent pelvis malignancies of female patients: a systematic review and meta-analysis. Zheng M; Xie D; Pan C; Xu Y; Yu W Nucl Med Commun; 2018 Jun; 39(6):479-485. PubMed ID: 29634659 [TBL] [Abstract][Full Text] [Related]
18. The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies. Grisaru D; Almog B; Levine C; Metser U; Fishman A; Lerman H; Lessing JB; Even-Sapir E Gynecol Oncol; 2004 Sep; 94(3):680-4. PubMed ID: 15350358 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of diffusion-weighted imaging versus 18F-FDG PET/CT in differentiating pulmonary lesions: an updated meta-analysis of comparative studies. Liu J; Xia X; Zou Q; Xie X; Lei Y; Wan Q; Li X BMC Med Imaging; 2023 Mar; 23(1):37. PubMed ID: 36899303 [TBL] [Abstract][Full Text] [Related]
20. Indirect comparison of the diagnostic performance of Hu X; Li D; Liang Z; Liao Y; Yang L; Wang R; Wang P; Cai J BMC Cancer; 2021 Oct; 21(1):1080. PubMed ID: 34615498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]